Latest News
Ford Stock Retreats After CEO Warns of Chinese EV Threat to US Market
Ford shares gave up post-earnings gains after CEO Jim Farley warned Chinese automakers could enter the US market within 5-10 years. Q2 adjusted EPS beat estimates at $0.42, but Model e losses remain substantial.
Dow Surges 615 Points, But Rally Relies on Just Two Stocks
The Dow closed up 615 points, but nearly all gains came from Microsoft and Goldman Sachs, highlighting a fragile rally.
Ambev ADRs Recover from Steep Drop as Cash Flow Surge Fuels Optimism
Ambev ADRs recovered sharply after a 5.5% intraday slide, as Q2 operating cash flow jumped 54.5%, though 79% of the rise came from working capital.
Transocean Shares Up 2.2% on Merger Arbitrage Opportunity as Valaris Deal Spread Widens
Transocean shares advanced 2.2% amid a widening merger spread with Valaris to 2.4%, as regulatory milestones and robust Q2 guidance bolster arbitrage expectations.
UiPath Stock Slides on Weak ARR Growth Forecast for Q2
UiPath stock dropped 3.3% after the company projected Q2 net new ARR between $28M and $33M, a 38% decline from Q1, signaling decelerating growth.
Ellison Family Faces $9.8B Risk in Warner Bros. Deal, Exceeding Paramount's Value
The Ellison family's potential $9.8 billion liability in the Warner Bros. takeover exceeds Paramount's $8.66 billion market cap, as WBD shares trade at a discount and regulatory risks loom.
Corcept Shares Leap 27% on Strong Lifyorli Launch and Upbeat Guidance
Corcept Therapeutics shares jumped 27.4% after Q2 revenue rose 32% to $256.1M, driven by Lifyorli sales of $47.6M. The company lifted its 2026 revenue outlook to $1.1-1.2 billion.